Description
- Coughing
- Fever
- Weakness
- Chest pains
- Severe or persistent nausea
- Vomiting
- Diarrhea
- Eye discomfort
- Irritated or dry skin
- Inward growing eyelashes
- Unusual bruising or bleeding
- Loss of appetite
Details
Uses
Erlonat (Erlotinib) is a Kinase inhibitor which is primarily used to treat cell lung cancer, or pancreatic cancer when combined with a certain other medicine. It works by inhibiting growth to adjacent tissues in the body so that the cancerous cells slow down, allowing the patient a better environment to recover and fight the cancer naturally.
Typically, an adult patient will be instructed to take between 100mg and 150mg of Erlonat (Erlotinib), at least 1 hour before any meals or snacks and 2 hours after. Unless otherwise instructed, you should always swallow each tablet whole without chewing, crushing, splitting, or dissolving the tablet in liquid. Wash tablets down with full glass of water.
Patients using Erlonat (Erlotinib) may experience the following side effects. Notify your physician promptly if you notice any side effects, whether listed below or not.
